gerd and glp-1 GI Hepatology News Targeting GLP-1, GIP & GCG

Cagrilintide Overview Cagrilintide stands as the first long-acting amylin analogue specifically engineered for once-weekly administration, addressing the limitations of earlier amylin-based therapeutics like pramlintide

The non-oxidative phase, which converts ribulose-5-phosphate into ribose-5-phosphate for nucleotides and nucleic acids, as well as glycolytic intermediates such as fructose-6-phosphate and G3P

Remarkably, similar genetic changes were observed in mice treated with rapamycin, a drug that inhibits our master nutrient sensor, mTOR (mechanistic target of rapamycin)

In rats given BPC-157, serotonin levels in the brain increase in specific regions while simultaneously decreasing in other regions, such as the hippocampus.[ref] A 2020 study found that BPC-157 reduced leaky gut syndrome by stabilizing gut permeability after NSAID use.[ref] Reducing leaky gut theoretically can affect the gut-brain axis and reduce inflammation

Frequent missed doses do reduce effectiveness, so work on strategies to improve adherence if this becomes a pattern

It has been used to neutralize free radicals and eventually ease oxidative stress